Our Business Development Manager and Study Director Elsa Kress will attend Oncology Virtual Partnering meeting from September 22 to 24. Get in touch with her to find out more about our preclinical evaluation services in the field of oncology! Looking forward to […]
We are proud to announce that the rewiew of our CIFRE PhD candidate Morgane Denis, on How can immune checkpoint inhibitors cause hyperprogression in solid tumours? is now published in Frontiers in Immunology!
We are pleased to announce that we are now a registered supplier for Scientist.com! Do not hesitate to enquire for a quotation!
We are thrilled to announce that our BD Director Elsa Kress will participate to the very first Digital Edition of the BES 2020! Science and networking make do in times of crisis! Contact her to organise a video meeting!
We are attending the Toulouse OncoWeek 2020. We are looking forwards to discuss our original tumour models of acquired resistances, which fit perfectly in the theme of this year’s TOW: Overcoming resistance to cancer therapies! Contact us to ask for […]
We wish you all the best for the year 2020!
For a 5 months contract, in replacement of Doriane during her maternity leave, we are looking for a Study Manager!Antineo-Profil-Remplacement2020
Our Business Development Manager and Study Director Elsa Kress will attend Biofit in Marseille from December 10th to 11th. Get in touch with her to find out more about our preclinical evaluation services in the field of oncology!
Now online, the Information Sheets for our Solid Tumours CDX models! Check out our human tumour models of gastrointestinal tractus.
Our team is glad to attend Festival of Biologics’ congress from October 15 to 17 in Basel, Switzerland. If you wish to learn more about Antineo’s preclinical evaluation expertise, we will be very happy to arrange a meeting with our […]